These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 27185803

  • 21. Deletion of human metapneumovirus M2-2 increases mutation frequency and attenuates growth in hamsters.
    Schickli JH, Kaur J, Macphail M, Guzzetta JM, Spaete RR, Tang RS.
    Virol J; 2008 Jun 03; 5():69. PubMed ID: 18519001
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques.
    Guedj J, Piorkowski G, Jacquot F, Madelain V, Nguyen THT, Rodallec A, Gunther S, Carbonnelle C, Mentré F, Raoul H, de Lamballerie X.
    PLoS Med; 2018 Mar 03; 15(3):e1002535. PubMed ID: 29584730
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses.
    Westover JB, Sefing EJ, Bailey KW, Van Wettere AJ, Jung KH, Dagley A, Wandersee L, Downs B, Smee DF, Furuta Y, Bray M, Gowen BB.
    Antiviral Res; 2016 Feb 03; 126():62-8. PubMed ID: 26711718
    [Abstract] [Full Text] [Related]

  • 26. Human metapneumovirus induces more severe disease and stronger innate immune response in BALB/c mice as compared with respiratory syncytial virus.
    Huck B, Neumann-Haefelin D, Schmitt-Graeff A, Weckmann M, Mattes J, Ehl S, Falcone V.
    Respir Res; 2007 Jan 29; 8(1):6. PubMed ID: 17257445
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. IFN-λ drives distinct lung immune landscape changes and antiviral responses in human metapneumovirus infection.
    Sojati J, Parks OB, Zhang Y, Walters S, Lan J, Eddens T, Lou D, Fan L, Chen K, Oury TD, Williams JV.
    mBio; 2024 May 08; 15(5):e0055024. PubMed ID: 38530032
    [Abstract] [Full Text] [Related]

  • 30. Clinical Regimens of Favipiravir Inhibit Zika Virus Replication in the Hollow-Fiber Infection Model.
    Pires de Mello CP, Tao X, Kim TH, Vicchiarelli M, Bulitta JB, Kaushik A, Brown AN.
    Antimicrob Agents Chemother; 2018 Sep 08; 62(9):. PubMed ID: 29967017
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Inhibition of Human Metapneumovirus Binding to Heparan Sulfate Blocks Infection in Human Lung Cells and Airway Tissues.
    Klimyte EM, Smith SE, Oreste P, Lembo D, Dutch RE.
    J Virol; 2016 Oct 15; 90(20):9237-50. PubMed ID: 27489270
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Phosphorylation of Human Metapneumovirus M2-1 Protein Upregulates Viral Replication and Pathogenesis.
    Cai H, Zhang Y, Lu M, Liang X, Jennings R, Niewiesk S, Li J.
    J Virol; 2016 Aug 15; 90(16):7323-7338. PubMed ID: 27252537
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Favipiravir as a potential countermeasure against neglected and emerging RNA viruses.
    Delang L, Abdelnabi R, Neyts J.
    Antiviral Res; 2018 May 15; 153():85-94. PubMed ID: 29524445
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.